Vertex Pharmaceuticals Incorporated announced today that a reimbursement agreement was signed with the GKV-Spitzenverband for its CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel).

A study reveals that chronic fatigue may originate in the gut, where biological changes affect energy levels and immunity.

Additionally, the approval provides for a revision of ASCENIV’s prescribing information to expand the primary humoral immunodeficiency (“PI”) indication to pediatric patients two years of age and ...

AbbVie today announced the presentation of new data across its gastroenterology portfolio at the 2026 Digestive Disease Week (DDW) Annual Meeting, May 2-5 in Chicago. AbbVie will present 18 abstracts, ...

In The Young and the Restless, Cane Ashby’s arrest at the Genoa City Athletic Club threatens his planned bone marrow donation to save Malcolm Winters, who is critically ill with aplastic anemia. The ...

As other global companies race to find new gene therapies, Regeneron plans to make the new drug free for those in the US ...

Kidney disease is a common health problem, especially in older adults, but many people do not notice it until it becomes ...

The agreement ensures sustainable access to this innovative therapy for eligible patients ages 12 years and older in Germany- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today ...

Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well ...

Iron-rich foods, paired with vitamin C and smart supplementation, can prevent iron deficiency anemia while supporting energy metabolism, brain function, and immunity across the lifespan. Balanced ...

These findings are important because they suggest that more selective JAK inhibition, particularly targeting JAK1 or JAK2, can effectively reduce organ pathology and pathogenic IFN-γ-producing immune ...